BACKGROUND: Arrhythmogenic disorders occur in a broad spectrum of cardiac pathologies in the general population with a prevalence of 1:10,000 to 1:500. Genetic studies conducted during the past 20 years have markedly illuminated the genetic basis of inherited cardiac disorders. However, uncertainty exists regarding which genes should be included and routinely assessed on genetic testing panels. Here, we review the genetic basis of the most important arrhythmogenic disorders found in our laboratory since 2016 by next-generation sequencing (NGS) analysis. METHODS: We analyzed sequence data from 1,385 clinical index cases with a suspected diagnosis of long QT syndrome (LQTS), Brugada syndrome (BrS), catecholaminergic polymorphic ventricular tachycardia (CPVT), hypertrophic cardiomyopathy (HCM), dilatative cardiomyopathy (DCM) or arrhythmogenic right ventricular cardiomyopathy (ARVC). Genetic testing was performed by NGS using a custom design based on an Agilent SureSelectQXT. RESULTS: The detection rate of pathogenic or likely pathogenic variants was in the range of 16% for BrS to 40% for HCM. Only the few well known core genes and some additional side genes substantially contribute to the diagnostic sensitivity. CONCLUSIONS: Clinical testing provides a definitive diagnosis for many patients. The genetic result may be important for risk stratification, genetic counseling and, in some cases, treatment planning. Diagnostic panels should not be further expanded as inclusion of many genes rather produces variants of unclear significance and confusing reports. 2019 Cardiovascular Diagnosis and Therapy. All rights reserved.
BACKGROUND: Arrhythmogenic disorders occur in a broad spectrum of cardiac pathologies in the general population with a prevalence of 1:10,000 to 1:500. Genetic studies conducted during the past 20 years have markedly illuminated the genetic basis of inherited cardiac disorders. However, uncertainty exists regarding which genes should be included and routinely assessed on genetic testing panels. Here, we review the genetic basis of the most important arrhythmogenic disorders found in our laboratory since 2016 by next-generation sequencing (NGS) analysis. METHODS: We analyzed sequence data from 1,385 clinical index cases with a suspected diagnosis of long QT syndrome (LQTS), Brugada syndrome (BrS), catecholaminergic polymorphic ventricular tachycardia (CPVT), hypertrophic cardiomyopathy (HCM), dilatative cardiomyopathy (DCM) or arrhythmogenic right ventricular cardiomyopathy (ARVC). Genetic testing was performed by NGS using a custom design based on an Agilent SureSelectQXT. RESULTS: The detection rate of pathogenic or likely pathogenic variants was in the range of 16% for BrS to 40% for HCM. Only the few well known core genes and some additional side genes substantially contribute to the diagnostic sensitivity. CONCLUSIONS: Clinical testing provides a definitive diagnosis for many patients. The genetic result may be important for risk stratification, genetic counseling and, in some cases, treatment planning. Diagnostic panels should not be further expanded as inclusion of many genes rather produces variants of unclear significance and confusing reports. 2019 Cardiovascular Diagnosis and Therapy. All rights reserved.
Authors: Antoine Bondue; Eloisa Arbustini; Anna Bianco; Michele Ciccarelli; Dana Dawson; Matteo De Rosa; Nazha Hamdani; Denise Hilfiker-Kleiner; Benjamin Meder; Adelino F Leite-Moreira; Thomas Thum; Carlo G Tocchetti; Gilda Varricchi; Jolanda Van der Velden; Roddy Walsh; Stephane Heymans Journal: Cardiovasc Res Date: 2018-08-01 Impact factor: 10.787
Authors: Philippe Charron; Michael Arad; Eloisa Arbustini; Cristina Basso; Zofia Bilinska; Perry Elliott; Tiina Helio; Andre Keren; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Andreas Perrot; Claudio Rapezzi; Arsen Ristic; Hubert Seggewiss; Irene van Langen; Luigi Tavazzi Journal: Eur Heart J Date: 2010-09-07 Impact factor: 29.983
Authors: Chiara Di Resta; Alessandro Pietrelli; Simone Sala; Paolo Della Bella; Gianluca De Bellis; Maurizio Ferrari; Roberta Bordoni; Sara Benedetti Journal: Hum Mol Genet Date: 2015-07-28 Impact factor: 6.150
Authors: Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm Journal: Genet Med Date: 2015-03-05 Impact factor: 8.822
Authors: Roddy Walsh; Kate L Thomson; James S Ware; Birgit H Funke; Jessica Woodley; Karen J McGuire; Francesco Mazzarotto; Edward Blair; Anneke Seller; Jenny C Taylor; Eric V Minikel; Daniel G MacArthur; Martin Farrall; Stuart A Cook; Hugh Watkins Journal: Genet Med Date: 2016-08-17 Impact factor: 8.822
Authors: Harsha D Devalla; Roselle Gélinas; Elhadi H Aburawi; Abdelaziz Beqqali; Philippe Goyette; Christian Freund; Marie-A Chaix; Rafik Tadros; Hui Jiang; Antony Le Béchec; Jantine J Monshouwer-Kloots; Tom Zwetsloot; Georgios Kosmidis; Frédéric Latour; Azadeh Alikashani; Maaike Hoekstra; Jurg Schlaepfer; Christine L Mummery; Brian Stevenson; Zoltan Kutalik; Antoine Af de Vries; Léna Rivard; Arthur Am Wilde; Mario Talajic; Arie O Verkerk; Lihadh Al-Gazali; John D Rioux; Zahurul A Bhuiyan; Robert Passier Journal: EMBO Mol Med Date: 2016-12-01 Impact factor: 12.137
Authors: S Mohsen Hosseini; Raymond Kim; Sharmila Udupa; Gregory Costain; Rebekah Jobling; Eriskay Liston; Seema M Jamal; Marta Szybowska; Chantal F Morel; Sarah Bowdin; John Garcia; Melanie Care; Amy C Sturm; Valeria Novelli; Michael J Ackerman; James S Ware; Ray E Hershberger; Arthur A M Wilde; Michael H Gollob Journal: Circulation Date: 2018-09-18 Impact factor: 29.690
Authors: Gustav Ahlberg; Lena Refsgaard; Pia R Lundegaard; Laura Andreasen; Mattis F Ranthe; Nora Linscheid; Jonas B Nielsen; Mads Melbye; Stig Haunsø; Ahmad Sajadieh; Lu Camp; Søren-Peter Olesen; Simon Rasmussen; Alicia Lundby; Patrick T Ellinor; Anders G Holst; Jesper H Svendsen; Morten S Olesen Journal: Nat Commun Date: 2018-10-17 Impact factor: 14.919
Authors: Anna Gaertner; Julia Bloebaum; Andreas Brodehl; Baerbel Klauke; Katharina Sielemann; Astrid Kassner; Henrik Fox; Michiel Morshuis; Jens Tiesmeier; Uwe Schulz; Ralph Knoell; Jan Gummert; Hendrik Milting Journal: Genes (Basel) Date: 2021-06-08 Impact factor: 4.096